General description
Daunorubicin is an anthracycline antineoplastic agent that inhibits DNA and RNA synthesis. It is used in treatment protocols for acute lymphoblastic leukaemia, acute myelogenous leukaemia and acute promyelocytic leukaemia.
INN
Daunorubicin
ATC codes
Medicine type
Chemical agent
EML status history
First added in 1999
(TRS
895)
for
Lymphoid leukaemia, not elsewhere classified
Added in 1999
(TRS
895)
for
Acute myeloid leukaemia with recurrent genetic abnormalities
Added in 1999
(TRS
895)
for
Myeloid leukaemia
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Parenteral > General injections > IV: 50 mg in vial (as hydrochloride) powder for injection; 20 mg in vial (as hydrochloride) powder for injection; 2 mg per mL in vial (as hydrochloride); 5 mg per mL in vial (as hydrochloride)